




























Publisher's PDF, also known as Version of record
Link to publication record in King's Research Portal
Citation for published version (APA):
McCarthy, K., Carter, B., Myint, P., Quinn, T. J., & Hewitt, J. (2020). Frailty and mortality in patients with COVID-
19 – Authors' reply. The Lancet Public Health, 5(11), E582. https://doi.org/10.1016/S2468-2667(20)30224-3
Citing this paper
Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may
differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination,
volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are
again advised to check the publisher's website for any subsequent corrections.
General rights
Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights.
•Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research.
•You may not further distribute the material or use it for any profit-making activity or commercial gain
•You may freely distribute the URL identifying the publication in the Research Portal
Take down policy
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing details, and we will remove access to
the work immediately and investigate your claim.
Download date: 01. Feb. 2021
Correspondence
www.thelancet.com/public-health   Vol 5   November 2020 e582
5 De Smet R, Mellaerts B, Vandewinckele H et al. 
Frailty and mortality in hospitalized 
older adults with COVID-19: retrospective 
observational study. J Am Med Dir Assoc 2020; 
21: 928–32.
6 Elshazli RM, Toraih EA, Elgaml A, et al. 
Diagnostic and prognostic value of 
hematological and immunological markers 
in COVID-19 infection: a meta-analysis of 
6320 patients. PLoS ONE 2020; published 
online Aug 21. https://doi.org/10.1371/
journal. pone.0238160.
7 Aw D, Woodrow L, Ogliari G, Harwood R. 
Association of frailty with mortality in older 
inpatients with COVID-19: a cohort study. 
Age Ageing 2020; published online Aug 10. 
https://doi.org/10.1093/ageing/afaa184.
Authors’ reply
We thank all the research teams who 
have submitted letters in response to 
our frailty and COVID-19 paper.1 This 
study has generated discussion in 
scientific journals, lay press, and social 
media. We welcome the opportunity 
to further discuss our methods and 
results. 
Laurent, Darvall and colleagues, and 
Pareek and colleagues, all question 
the use of the Clinical Frailty Scale 
(CFS) as a tool for decision making 
during the COVID-19 pandemic. It 
was not our intention to promote 
the practice of basing treatment 
escalation plans on frailty status. In 
fact, we cautioned against the use of 
age alone in establishing treatment 
type.2 However, in the UK, CFS scoring 
was recommended at the government 
level for triaging patients with 
COVID-19,3 and so the exploration 
of the properties of the CFS in this 
context seemed timely and relevant. 
Use of frailty assessments in COVID-19 
care is not exclusive to the UK; 
Rockwood and Theou4 highlighted the 
need for all health-care professionals 
working with patients with COVID-19 
to familiarise themselves with frailty 
assessment.
Laurent requests data on C reactive 
protein (CRP) in light of their work 
showing no relationship between 
CRP and mortality in COVID-19.5 In 
contrast, we found that for a pre-
specified threshold of CRP of 40 mg/L 
or more on admission, mortality was 
31·9% compared with 15·0% if CRP 
was lower than 40 mg/L (n=1564; 
adjusted HR=2·61 [95% CI 1·97–3·45]; 
p<0·0001). Among those who died, 
median CRP was 115 (IQR: 63–191) 
compared with 69 (IQR: 29–140) 
among patients who survived. Our 
findings concur with those from 
other studies, suggesting admission 
CRP can guide the management of 
COVID-19.6
Thus, our data highlight various risk 
factors for poor outcome in patients 
admitted with COVID-19. We limited 
our data collection to factors initially 
believed to influence prognosis. 
Subsequently, other important risk 
factors have emerged; for example, 
obesity and ethnicity. All these 
data improve our understanding of 
COVID-19 and might improve its 
management. However, risk factors 
should not be used in isolation, but 
rather should inform care discussions 
with patients and families. With a 
second wave of COVID-19 in the UK 
and many European countries, these 
discussions might once again become 
a common part of clinical practice.
Since our paper,1 other studies 
of frailty and COVID-19 have been 
reported. Those that made use of a 
similar prospective, sequential data 
collection, and follow-up approach 
have also found associations between 
frailty and a poor outcome.7 We 
acknowledge that there are many 
unanswered questions around this 
topic. Our study was an international 
collaborative effort, and in this 
spirit, we are happy to work with any 
future studies that will enhance our 
understanding of COVID-19 and frailty.
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